- Home
- EML vs DERM Comparison
EML vs DERM Comparison
Compare EML & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EML
- DERM
- Stock Information
- Founded
- EML 1858
- DERM 2014
- Country
- EML United States
- DERM United States
- Employees
- EML N/A
- DERM N/A
- Industry
- EML Industrial Machinery/Components
- DERM Biotechnology: Pharmaceutical Preparations
- Sector
- EML Consumer Discretionary
- DERM Health Care
- Exchange
- EML Nasdaq
- DERM Nasdaq
- Market Cap
- EML 146.7M
- DERM 165.6M
- IPO Year
- EML N/A
- DERM 2021
- Fundamental
- Price
- EML $25.38
- DERM $7.17
- Analyst Decision
- EML
- DERM Strong Buy
- Analyst Count
- EML 0
- DERM 3
- Target Price
- EML N/A
- DERM $12.67
- AVG Volume (30 Days)
- EML 10.7K
- DERM 134.4K
- Earning Date
- EML 11-04-2025
- DERM 11-11-2025
- Dividend Yield
- EML 1.73%
- DERM N/A
- EPS Growth
- EML N/A
- DERM N/A
- EPS
- EML N/A
- DERM N/A
- Revenue
- EML $269,054,445.00
- DERM $56,397,000.00
- Revenue This Year
- EML $1.56
- DERM $28.10
- Revenue Next Year
- EML $7.00
- DERM $53.84
- P/E Ratio
- EML $13.98
- DERM N/A
- Revenue Growth
- EML 1.30
- DERM N/A
- 52 Week Low
- EML $19.06
- DERM $3.54
- 52 Week High
- EML $35.03
- DERM $8.90
- Technical
- Relative Strength Index (RSI)
- EML 60.90
- DERM 48.65
- Support Level
- EML $23.50
- DERM $7.00
- Resistance Level
- EML $25.46
- DERM $7.12
- Average True Range (ATR)
- EML 0.69
- DERM 0.27
- MACD
- EML 0.16
- DERM -0.00
- Stochastic Oscillator
- EML 93.03
- DERM 45.86
About EML Eastern Company (The)
The Eastern Co manages industrial businesses that design, manufacture, and sell engineered solutions to industrial markets. The company manages the financial, operational, and strategic performance of its businesses to increase cash generation, operating earnings, and long-term shareholder value. It operates in the United States and Other Countries and generates the majority of its revenue from the United States.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.